Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Endotoxin Testing Industry Compare Between 2025 And 2029?
The endotoxin testing market has shown continuous expansion in recent years. Its size is expected to climb from $2.24 billion in 2024 to $2.31 billion by 2025, achieving a compound annual growth rate (CAGR) of 3.4%. This historical growth can be attributed to several factors, including the increasing demand for biologics and biosimilars, a heightened awareness regarding the importance of endotoxin testing, and the growing prevalence of infectious diseases.
The endotoxin testing market is projected to experience substantial expansion over the coming years. This market is set to reach $2.91 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.9%. Several factors contribute to this anticipated growth during the forecast period, including the burgeoning biopharmaceutical industry, increased investment in endotoxin testing research and development, and the worldwide expansion of healthcare. Significant developments expected in this period encompass novel endotoxin detection tools, a greater uptake of endotoxin testing services, and a rise in the overall demand for these services.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp
Which Drivers Are Supporting Growth Of The Endotoxin Testing Market?
The rise in healthcare-associated infections is anticipated to drive the expansion of the endotoxin testing market. These infections are acquired by patients during medical treatment and were not present upon hospital admission. Often originating from tainted medical equipment or procedures, healthcare-associated infections necessitate stringent testing to ensure patient well-being. Endotoxin testing services play a crucial role in preventing these infections by evaluating bacterial endotoxin levels in medical devices, particularly injectable pharmaceutical products and implantable medical devices. For example, in December 2022, the United Nations International Children’s Emergency Fund (UNICEF), a US-based agency of the United Nations, reported that pneumonia was the leading infectious cause of child deaths, claiming over 700,000 lives annually, which translates to about 2,000 children daily. Moreover, in May 2022, the World Health Organization, a Switzerland-based agency of the United Nations, indicated that 24% of patients are affected by healthcare-associated sepsis each year, with 52.3% of those treated in an intensive care unit succumbing annually. Consequently, the increasing prevalence of healthcare-associated infections is stimulating the growth of the endotoxin testing market.
How Is The Endotoxin Testing Market Classified Into Different Segments?
The endotoxin testingmarket covered in this report is segmented –
1) By Test Type: LAL (Limulus Amebocyte Lysate) Test; Chromogenic Tests; Turbidimetric Tests; Gel Clot Tests; MAT Test; Rabbit Pyrogen Test; Recombinant Factor C (rFC) Assay
2) By Application: Medical Devices; Pharmaceuticals; Packaging; Raw Materials
3) By End-User: Hospitals; Laboratories; Research Institutes
Subsegments:
1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test; Kinetic LAL Test; Endpoint LAL Test
2) By Chromogenic Tests: Chromogenic LAL Test; Chromogenic Factor C Assay
3) By Turbidimetric Tests: Turbidimetric LAL Test; Turbidimetric Factor C Assay
4) By Gel Clot Tests: Gel Clot LAL Test
5) By MAT Test (Monocyte Activation Test): Direct MAT; Indirect MAT
6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test
7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection
What Long-Term Trends Will Shape The Future Growth Of The Endotoxin Testing Industry?
Leading firms within the endotoxin testing market prioritize the adoption of advanced technological solutions to maintain their competitive standing. An example of this strategy is seen in August 2023, when Lonza Group AG, a pharmaceutical, biotechnology, and nutrition manufacturing company based in Switzerland, unveiled the Nebula absorbance reader, an innovative absorbance microplate reader designed to simplify endotoxin and pyrogen testing. This device offers complete connectivity with Lonza’s latest WinKQCL software, thereby aiding in data integrity compliance, accelerating user training, and reducing the validation burden. Consequently, users of the WinKQCL software no longer need to acquire proficiency in new software to operate this modern reader, which significantly lowers training requirements. The Nebula Absorbance Reader stands as an innovative and technologically sophisticated substitute, delivering results comparable to those typically obtained with the ELx808, the industry-standard absorbance reader no longer sold by Lonza. Furthermore, its design ensures compatibility with and adherence to the stringent specifications of Lonza’s absorbance-based endotoxin assays, encompassing the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.
Who Are The Primary Competitors In The Global Endotoxin Testing Market?
Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report
Which Region Shows The Highest Potential For Future Expansion In The Endotoxin Testing Market?
North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Endotoxin Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12932&type=smp
Browse Through More Reports Similar to the Global Endotoxin Testing Market 2025, By The Business Research Company
Hospital Acquired Infections Testing Kits Global Market Report 2025
Non Animal Alternatives Testing Global Market Report 2025
Pharma Microbiology Testing Kits Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model